DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes

Yong H. Woo, Wen Hsiung Li*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    97 Scopus citations

    Abstract

    Cancer cells evolve from normal cells by somatic mutations and natural selection. Comparing the evolution of cancer cells and that of organisms can elucidate the genetic basis of cancer. Here we analyse somatic mutations in >400 cancer genomes. We find that the frequency of somatic single-nucleotide variations increases with replication time during the S phase much more drastically than germ-line single-nucleotide variations and somatic large-scale structural alterations, including amplifications and deletions. The ratio of nonsynonymous to synonymous single-nucleotide variations is higher for cancer cells than for germ-line cells, suggesting weaker purifying selection against somatic mutations. Among genes with recurrent mutations only cancer driver genes show evidence of strong positive selection, and late-replicating regions are depleted of cancer driver genes, although enriched for recurrently mutated genes. These observations show that replication timing has a prominent role in shaping the single-nucleotide variation landscape of cancer cells.

    Original languageEnglish (US)
    Article number1004
    JournalNature Communications
    Volume3
    DOIs
    StatePublished - 2012

    Bibliographical note

    Funding Information:
    This work was supported by James Watson Professorship, University of Chicago and Academia Sinica, Taiwan. We thank Adam Eyre-Walker for valuable comments. The data reported in the paper are obtained from publicly available data repositories.

    ASJC Scopus subject areas

    • General Chemistry
    • General Biochemistry, Genetics and Molecular Biology
    • General Physics and Astronomy

    Fingerprint

    Dive into the research topics of 'DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes'. Together they form a unique fingerprint.

    Cite this